Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0000912282-24-000017
Filing Date
2024-01-09
Accepted
2024-01-09 11:40:16
Documents
1
Effectiveness Date
2024-01-09
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8561
  Complete submission text file 0000912282-24-000017.txt   9677
Mailing Address 9 MEZADA STREET BSR 3 TOWER, 30 FLOOR BNEI-BRAK L3 5120109
Business Address 9 MEZADA STREET BSR 3 TOWER, 30 FLOOR BNEI-BRAK L3 5120109 972 52-4803034
NurExone Biologic Inc. (Filer) CIK: 0001995074 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-501903 | Film No.: 24522338